Boris Johnson’s highly anticipated inaugural column for the Daily Mail has been met with widespread disappointment, challenging the claim that his musings would be considered “required reading across the world.”
Following his recent resignation from Parliament amidst findings of deliberately misleading the House, the Daily Mail announced on Friday that Johnson would be a regular full-page columnist every Saturday.
The paper boasted of their new signing, describing him as an “erudite new columnist who’ll be required reading in Westminster and across the world.” Reports suggest that he is being handsomely compensated for this role, earning £1 million per year.
However, it was soon revealed that Johnson had once again violated parliamentary rules by accepting the position.
Nevertheless, his first column was published shortly after, and it failed to deliver the profound insights into the inner workings of power that many had anticipated.
The online headline read: “The wonder drug I hoped would stop my 11.30 pm fridge raids for cheddar and chorizo didn’t work for me. But I still believe it could change the lives of millions.”
In his column, Johnson focused on the diabetes drug Ozempic, which has gained notoriety for its purported ability to help celebrities lose weight.
However, the former prime minister admitted that the drug did not have the same effect on him, as his weight continued to fluctuate until he relied on “exercise and willpower” instead.
Despite his personal experience, Johnson expressed hope that the drug could eventually benefit both himself and countless others, emphasizing the pressing issue of obesity in the UK. He remarked, “I believe we are still in the foothills of what these drugs can do.”
However, the reception on Twitter, to put it kindly, was lukewarm, with many expressing their disappointment and underwhelmed reactions to the column.
The post People Express Disappointment With Boris Johnson’s Inaugural Daily Mail Column appeared first on SurgeZirc UK.
